Kassin, Michael T.
Varble, Nicole
Blain, Maxime
Xu, Sheng
Turkbey, Evrim B.
Harmon, Stephanie
Yang, Dong
Xu, Ziyue
Roth, Holger
Xu, Daguang
Flores, Mona
Amalou, Amel
Sun, Kaiyun
Kadri, Sameer
Patella, Francesca
Cariati, Maurizio
Scarabelli, Alice
Stellato, Elvira
Ierardi, Anna Maria
Carrafiello, Gianpaolo
An, Peng
Turkbey, Baris
Wood, Bradford J.
Funding for this research was provided by:
NIAD NIH Intramural Targeted Anti-COVID-19 (ITAC) Grant
National Institutes of Health, Center for Interventional Oncology (Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242)
Philips Research Americas
French Society of Radiology Alain Rahmouni SFR-CERF research grant
NVIDIA Cooperative Research and Development Agreement
National Cancer Institute (75N91019D00024, 75N91019D00024)
National Institutes of Health
Article History
Received: 9 October 2020
Accepted: 3 March 2021
First Online: 25 March 2021
Competing interests
: The content of this publication does not necessarily reflect the views or policies of the National Institutes of Health, the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. MB is a recipient of the 2019 Alain Rahmouni SFR-CERF research grant provided by the French Society of Radiology together with the French Academic College of Radiology. NV is an employee of Philips Research North America. DY, ZX, HR, DX, MF are employees of NVIDIA corp. BW is Principal Investigator on the following CRADA’s (Cooperative Research & Development Agreements) between NIH and related commercial partners that involve artificial intelligence and deep learning: Philips Image Guided Therapy (CRADA), Philips Research (CRADA), Philips (CRADA), Siemens (CRADA), NVIDIA (CRADA). All other authors declare no competing interests.